| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.087 | 0.1 |